ELRIG Drug Discovery 2023 congress will take place in Liverpool next week (October, 18 & 19th 2023). Our project leader Dr. Véronique De Conto will have the pleasure for presenting a poster about High Content Screening in 3D models including the tumoral Extracellular Matrix. Abstract: In oncology, 97% of drug Read more…
HCS Pharma is very pleased to participate to “Building Biology in 3D” symposium of the Society for Laboratory Automation and Screening (SLAS), in Cambridge, United Kingdom 20-21 April 2023. Veronique De Conto, our project leader in in vitro pharmacology will present two digital posters about the use of BIOMIMESYS® hydroscaffold, Read more…
The congress of European Society of Toxicology In Vitro (ESTIV) took place from 21st to 25th November 2022. This congress is focus on the alternative methods to animal testing, including both in silico and in vitro modeling. After a nice opening ceremony with a flamenco show, the scientific program begun Read more…
Last week, our project leader Océane GUYOT was in Lisbon to participate in Skin Ageing & Challenges. We had the opportunity to present a short oral entitled Cell Imaging For Dermocosmetic Claims Substantation Through In Vitro Assessment On Cellular Skin Models. This presentation focused on the interest of cell imaging Read more…
We will have the pleasure to participate in the 13th Annual Meeting on Skin Ageing & Challenges which will be organized on November 17-18, 2022 at Altis Grand Hotel, Lisbon, Portugal and Online. This congress focus to provide answers and to give a future vision and trends on how can Read more…
Next month, we will have the pleasure to participate in the 23rd EUSAAT (EUropean Society for Alternative to Animal Testing) congress, which will take place in Linz (Austria) on the 26th-28th of September. We have proposed an abstract about how we use 3D in vitro cell culture models for recapitulating Read more…
We previously showed that human pluripotent stem cells (hiPSCs) provide a suitable model to studymetabolic diseases upon hepatocyte-like cell (HLC) differentiation. With a non-invasive approach, hiPSCs can be generated from urine samples of patients and HLCs have been used to model cholesterol metabolism regulation, by the study of LDLR- and Read more…
Elodie Vandenhaute (our project director), Véronique De Conto (our project leader in in vitro pharmacology) and Natacha Perrin (our trainee in neurosciences) were present at the annual SCMC (Société Cerveau et Maladies Cérébrovasculaires – The French Brain and Cerebrovascular Diseases Society) congress, which took place on the 16th of June Read more…
It is our pleasure to participate to the ECM2022 congress the 22th, 23th and 24th of June in Copenhagen with two contributions (abstracts at the end): Our project leader in iPSc and Metabolic diseases Meryl Roudaut will present his works about the development of innovative hiPSC-based model including an innovative Read more…
We are happy to participate in Cosmetotest, the first Symposium dedicated to preclinical and clinical tests in dermocosmetics the 24th and 25th of May at Lyon. HCS Pharma will be present for the preclinal day, the 24th of May. You could meet Océane (project leader) in this event to discuss about our Read more…
The 2nd congress of Centers of Excellence in Neurodegeneration (CoEN) took place in Lille on the 14th and 15th of November 2019. It was organized by the Lille Center of Excellence for Neurodegenerative Disorders (LICEND). This meeting welcomed seven French research centers of excellence in neurodegenerative diseases: Lille (LICEND), CoEN Read more…
The annual congress of Biology and Health PhD students from Lille (André Verbert day) took place at the Faculty of Medicine Thursday, September 10th. During this day, PhD students, in third year of thesis, had to present their works by talks, flash-talks or posters. Our PhD student Véronique De Conto Read more…
The annual SCMC congress (Société Cerveau et Maladies Cérébrovasculaires – Brain and Cerebrovascular diseases Society) took place in Lille last week, in the Faculty of Medecine. The congress was organized in three sessions. The first session was about cerebrovascular development and maturation. The conferences began with a lecture about blood-brain Read more…
The annual meeting of the Society for the Study of Blood Brain interface (SEISC) took place in Paris the 9th November 2018. All day long, recent studies adressing different BBB issues have been presented, including Blood-Brain Barrier (BBB) development, molecular control, and several pathological aspects. BBB development: The meeting started Read more…
HCS Pharma will be present to the annual congress of the Society of Study of Blood-Brain Interfaces (SEISC) at Collège de France on Friday, November 9th 2018. The congress will begin by a plenary lecture about the molecular control of neurovascular development, given by Isabelle Brunet (CIRB, Collège de France), Read more…
Are your interested in meaning full images and high content analysis to asses your compounds properties ? Pierre-Jean, our dermocosmetic expert, will be present at Cosmetic 360 (the international trade fair for innovative ideas and solutions in the fragrance and cosmetics industry), 17th and 18th of October 2018 at Carrousel du Louvre in Read more…
Our CEO will be in Boston from Monday (November 7) to Wednesday (November 9).
Curious about our toxicology and phenotypic screening services ?
ESTIV conference, named In Vitro Toxicology for Human Safety Assessment, takes place this week in Juan-les-Pins. This congress brings together a lot of toxicologists, from public and private, to discuss the last development of predictive in vitro models in safety testing, as 3D models, organ-on-a-chip, bioprint organs. To learn more and to exchange on these Read more…
We were present in the innovation zone of Drug Discovery 2015 congress last week in Telford. We had the opportunity to present our work with two posters.
Join us for the next ELRIGfr conference in Brussels, the 14th & 15th of october.
Come and joins us to the congress organised by ELRIG: drug discovery 2014. A specific new session on phenotypic discovery and cellular imaging will be implemented in the 2014 programm. I you want to learn more about this congress and to register, follow this link! We are pleased to see you Read more…